AstraZeneca
Endometrial Cancer Care Improvement and Policy Report
Pages
85
Time to read
169 mins
Publication
Language
English
Pages
85
Time to read
169 mins
Publication
Language
English
This report focuses on endometrial cancer, which constitutes approximately 90% of uterine cancer cases and is the most common gynecological cancer in high-income regions such as the European Union and Northern America. It affects around 154,000 women annually, surpassing the combined incidence of cervical and ovarian cancers. The report outlines the rising incidence and mortality rates attributed to factors like obesity, which significantly increases the risk of developing endometrial cancer. It highlights the economic burden this disease imposes on society and notes the lack of global policy initiatives aimed at addressing endometrial cancer, contrasting it with the attention given to other cancer types by organizations like the World Health Organization. The report discusses disparities in outcomes based on socioeconomic and ethnic factors, emphasizing the need for increased awareness, equitable healthcare solutions, and research funding to improve care pathways for women affected by this cancer. It concludes with recommendations for policymakers to take action.